Lifeline for myeloma patients: continued access to promising drug

NCT ID NCT06057402

Recruiting now Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study offers ongoing access to the drug elranatamab for people with multiple myeloma who were already benefiting from it in earlier Pfizer studies. The goal is to keep providing the treatment while monitoring for any side effects. About 80 participants will take part, and the study is currently recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Locations

Arthur J.E. Child Comprehensive Cancer Centre
RECRUITING

Calgary, Alberta, T2N 5GN, Canada
Clinica Universidad de Navarra
RECRUITING

Pamplona, Navarre, 31008, Spain
Cross Cancer Institute
RECRUITING

Edmonton, Alberta, T6G 1Z2, Canada
Epworth Freemasons
RECRUITING

Melbourne, Victoria, 3002, Australia
Epworth Hospital
RECRUITING

Richmond, Victoria, 3121, Australia
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)
RECRUITING

Detroit, Michigan, 48202, United States
Hospital Universitario Doctor Peset
RECRUITING

Valencia, València, 46017, Spain
Japanese Red Cross Medical Center
RECRUITING

Shibuya-ku, Tokyo, 150-8935, Japan
Longs Peak Hospital
RECRUITING

Longmont, Colorado, 80504, United States
McGill University Health Centre
RECRUITING

Montreal, Quebec, H4A 3J1, Canada
National Taiwan University Hospital
RECRUITING

Taipei, 10002, Taiwan
Peking University Third Hospital
ACTIVE_NOT_RECRUITING

Beijing, Beijing Municipality, 100191, China
Shandong Provincial Hospital
RECRUITING

Jinan, Shandong, 250021, China
Slade Pharmacy
RECRUITING

Richmond, Victoria, 3121, Australia
St. David's South Austin Medical Center
RECRUITING

Austin, Texas, 78704, United States
Sun Yat-sen University Cancer Center
ACTIVE_NOT_RECRUITING

Guangzhou, Guangdong, 510555, China
Sylvester Comprehensive Cancer Center
RECRUITING

Miami, Florida, 33136, United States
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
RECRUITING

Coral Gables, Florida, 33146, United States
Taipei Veterans General Hospital
RECRUITING

Taipei, 11217, Taiwan
The first Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, 310003, China
UC Irvine Health
RECRUITING

Orange, California, 92612, United States
UCHealth - Medical Center of the Rockies
RECRUITING

Loveland, Colorado, 80538, United States
UCHealth Greeley Hospital
RECRUITING

Greeley, Colorado, 80634, United States
UCHealth Harmony
RECRUITING

Fort Collins, Colorado, 80528, United States
UCHealth Longs Peak Medical Center
RECRUITING

Longmont, Colorado, 80504, United States
UCHealth Poudre Valley Hospital
RECRUITING

Fort Collins, Colorado, 80524, United States
UCI Health
RECRUITING

Orange, California, 92868, United States
UCI Health - Irvine Infusion Pharmacy ACC
RECRUITING

Irvine, California, 92612, United States
University Hospital,Kyoto Prefectural University of Medicine
RECRUITING

Kyoto, 602-8566, Japan
University of Miami Hospital and Clinics
RECRUITING

Miami, Florida, 33136, United States
University of Miami Hospital and Clinics - Griffin Cancer Research Building
RECRUITING

Miami, Florida, 33136, United States
University of Miami Hospital and Clinics Deerfield Beach
RECRUITING

Deerfield Beach, Florida, 33442, United States
University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.